Wednesday, October 14, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· December 22, 2025

Un-carrier Unwrapped 2025

View original at finance.yahoo.com
Un-carrier Unwrapped 2025 T-Mobile unwraps its biggest moments of 2025.The Un-carrier built the nation’s best network and powered connection like never before.T-Mobile delivers the best value by giving its members more, just for choosing the Un-carrier.T-Mobile is all about seamlessly connecting people to everything th…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • T-Priority introduced the nation's first network slice for first responders

    80% confidence
  • L4S is a first-of-its-kind U.S. technology that delivers smoother, more responsive performance even when networks are busy

    80% confidence
  • T-Mobile became the first in the U.S. to launch 5G Advanced nationwide

    80% confidence
  • T-Mobile delivered its strongest quarter in more than a decade

    80% confidence
  • T-Mobile is America's Best Mobile Network based on analysis of half a billion data points from millions of devices in H1 2025

    80% confidence
  • More than half a million messages were sent via T-Satellite during 2025's natural disasters

    80% confidence
  • Southwest is the largest U.S. airline to offer free Wi-Fi on every flight

    80% confidence
  • Experience Beyond delivers over $200 in added value for every line each month

    80% confidence
  • Families can save up to 20% when switching from AT&T and Verizon by getting built-in benefits they leave out

    80% confidence
  • SuperMobile features the first and only nationwide network slice built for business

    80% confidence
  • T-Mobile is one of the Best Workplaces for Innovators

    80% confidence
  • More than 150,000 people rely on T-Satellite every day

    80% confidence
  • T-Satellite is helping to save lives nearly every day

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,375 source documents archived
Query this data → isubstrate.com